Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Lymphoma × Famotidine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cyclophosphamide 54 Vincristine 52 Doxorubicin 50 Rituximab 43 Prednisone 40 Etoposide 33 Radiotherapy 32 Cytarabine 24 Filgrastim 20 Methotrexate 18 Bleomycin 18 Dexamethasone 16 Carmustine 13 Vinblastine 12 VAP-cyclo protocol 11 Prednisolone 11 Peripheral Blood Stem Cell Transplantation 11 Melphalan 11 Mitoxantrone 9 Mercaptopurine 9 Dacarbazine 9 Leucovorin 8 Procarbazine 7 Lenalidomide 7 Ifosfamide 7 Granulocyte Colony-Stimulating Factor 7 Gemcitabine 7 ibrutinib 6 Epoetin Alfa 6 Daunorubicin 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03647072 2018-08-27

PPI Versus Histamine Antagnists as Adjuvant to Chemotherapy

Tanta University

Phase 3 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡